Success Metrics

Clinical Success Rate
90.0%

Based on 9 completed trials

Completion Rate
90%(9/10)
Active Trials
2(13%)
Results Posted
44%(4 trials)
Terminated
1(7%)

Phase Distribution

Ph phase_2
1
7%
Ph phase_1
4
27%
Ph phase_3
10
67%

Phase Distribution

4

Early Stage

1

Mid Stage

10

Late Stage

Phase Distribution15 total trials
Phase 1Safety & dosage
4(26.7%)
Phase 2Efficacy & side effects
1(6.7%)
Phase 3Large-scale testing
10(66.7%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

81.8%

9 of 11 finished

Non-Completion Rate

18.2%

2 ended early

Currently Active

2

trials recruiting

Total Trials

15

all time

Status Distribution
Active(2)
Completed(9)
Terminated(2)
Other(2)

Detailed Status

Completed9
unknown2
Recruiting2
Terminated1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
15
Active
2
Success Rate
90.0%
Most Advanced
Phase 3

Trials by Phase

Phase 14 (26.7%)
Phase 21 (6.7%)
Phase 310 (66.7%)

Trials by Status

terminated17%
unknown213%
completed960%
withdrawn17%
recruiting213%

Recent Activity

Clinical Trials (15)

Showing 15 of 15 trials
NCT03113994Phase 2

Statin Monotherapy for Treatment of Endocrine Metabolic Disease Risk

Terminated
NCT04319627Phase 3

Statins for Venous Event Reduction in Patients With Venous Thromboembolism

Recruiting
NCT04602754Phase 3

Efficacy and Safety of Berlim 25/20 Association in the Treatment of Type II Diabetes Mellitus and Dyslipidemia.

Recruiting
NCT06081166Phase 1

A Drug-drug Interaction Study Evaluating the PK Effects of Obicetrapib on Atorvastatin and Rosuvastatin

Completed
NCT05828303Phase 1

A Phase 1 Study to Evaluate the Potential Drug Interactions Between Repotrectinib and Metformin, Digoxin, and Rosuvastatin in Patients With Advanced Solid Tumors

Withdrawn
NCT04603508Phase 3

Efficacy and Safety of Berlim 25/10 Association in the Treatment of Type II Diabetes Mellitus and Dyslipidemia

Unknown
NCT04621669Phase 1

Drug-durg Interaction of SHR3680 With Digoxin, Rosuvastatin Calcium and Metformin Hydrochloride

Unknown
NCT01078675Phase 3

An Study to Evaluate Rosuvastatin in Children and Adolescents With Familial Hypercholesterolaemia

Completed
NCT00463606Phase 3

A Multicenter Study Comparing the Safety and Efficacy of ABT-335 and Rosuvastatin Calcium Combination Therapy to Monotherapy in Subjects With Dyslipidemia

Completed
NCT00491530Phase 3

A Year 2, Safety Extension Study of the Combination of ABT-335 and Statin Therapy for Subjects With Mixed Dyslipidemia

Completed
NCT00225589Phase 3

A Study Measuring Effects on Intima Media Thickness: An Evaluation of Rosuvastatin 40 mg (METEOR)

Completed
NCT00240318Phase 3

A Study To Evaluate the Effect of Rosuvastatin On Intravascular Ultrasound-Derived Coronary Atheroma Burden (ASTEROID)

Completed
NCT00214630Phase 3

LUNAR IIIb Study Comparing Rosuvastatin and Atorvastatin in Subjects With Acute Coronary Syndromes

Completed
NCT00300482Phase 3

Evaluate Safety and Efficacy of ABT-335 in Combination With Rosuvastatin Calcium in Subjects With Multiple Abnormal Lipid Levels in the Blood

Completed
NCT00766025Phase 1

Study in Taiwanese Subjects Identified as CYP2C19 Poor and Extensive Metabolizers Receiving Rosuvastatin

Completed

All 15 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
15